Risk for Depressive Symptoms Increased for Perimenopausal Women
By Elana Gotkine HealthDay Reporter
THURSDAY, May 9, 2024 -- Perimenopausal women have an increased risk for depressive symptoms and diagnoses, according to a review published in the July 15 issue of the Journal of Affective Disorders.
Yasmeen Badawy, from University College London, and colleagues conducted a systematic review and meta-analysis to estimate the risk for developing clinical depression and depressive symptoms at different stages of menopause. Data from 17 prospective cohort studies with 16,061 women were included in the review. The meta-analyses included seven studies with 9,141 participants.
The researchers found that compared with premenopausal women, perimenopausal women had a significantly higher risk for depressive symptoms and diagnoses (odds ratio, 1.40). No significantly increased risk for depressive symptoms or diagnoses was seen for postmenopausal versus premenopausal women.
"Our study further solidifies the existing evidence on the association between the perimenopausal stage and the risk for depressive symptoms, including a significantly larger number and more diverse studies than in previous meta-analyses," the authors write. "Our findings highlight the need for early screening and treatment for depression in midlife women and further research into potential risk factors."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
High Social Media Use Tied to Depression in Only Some Teens
TUESDAY, July 2, 2024 -- High social media use is only tied to increased depression in teens who are already vulnerable, according to a study published online June 26 in...
Small Differences in Weight Change With First-Line Antidepressants
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...
Acupuncture Reduces Endocrine Symptoms, Hot Flashes in Breast Cancer
MONDAY, June 24, 2024 -- A 10-week acupuncture intervention significant reduces endocrine symptoms and hot flashes among women with breast cancer receiving endocrine therapy (ET)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.